Cell And Gene Therapy Manufacturing

  1. Validation Of A qPCR Assay For Host Cell DNA Quantitation 6/9/2025

    Here, we share the development and validation of a new, highly sensitive and accurate integrated solution for detection and quantitation of host cell DNA to help meet regulatory requirements.

  2. CTS OpTmizer One SFM: Thoughtfully Designed Nutrition For T Cells 5/22/2025

    Learn about a novel, next-generation medium with an animal-component-free formulation developed to support the need for a T-cell medium that allows consistent, reproducible, and automated T-cell manufacturing.

  3. Singapore Single-Use Site Capacity Expansion 6/1/2022

    Thermo Fisher Scientific is expanding our single-use manufacturing network globally, an expansion site closer to Asia Pacific region

  4. Fast Track Your Path To Commercialization 5/21/2025

    Discover key strategies for scaling biologics from bench to pilot scale and learn how to overcome challenges in process development, including control of agitation, oxygen, CO₂, and nutrient supplementation.

  5. Unlocking The Future Of Allogeneic Cell Therapy For Oncology | Audience Q&A 5/6/2024

    Expert panelists in this Cell & Gene Therapy Live presentation provided detailed responses to questions about the potential risks of CAR-T therapy, screening criteria for donor material, comparability, and more.

  6. Technology Needs For Automated Manufacturing 8/18/2023

    Investigate the importance of technology as it relates to automation and standardization within cell therapy manufacturing. The panelists in this discussion cover solutions and services needed for process automation in CGT.

  7. DynaDrive S.U.B. Video Series 4/1/2026

    Explore DynaDrive Single-Use Bioreactors through expert videos covering reactor design, mixing performance, sparge technology, and scalable workflows from bench-scale to commercial production.

  8. What's New for 2024: Dr. Nicole Verdun Offers a Look Inside The Office Of Therapeutic Products 1/30/2024

    What is the Office of Therapeutic Products, where did it originate, and what's on its regulatory agenda for 2024?

  9. Best Practices For Effective Donor Management 5/6/2024

    Starting with high quality donor material is critical for allogeneic cell therapy drug manufacturing, and this requires laying the groundwork for a high-touch, end-to-end donor pool management strategy.

  10. Scaling Viral Vectors 11/13/2023

    Industry experts cover the high operational costs associated with viral vectors, along with the challenge presented by their shot shelf life and scalability.